Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent

A Phase 2, Randomized, Double-Blind, Multicenter Trial To Evaluate the Safety and Efficacy of Three Dosing Regimens of Isavuconazole Compared with Fluconazole in Patients with Uncomplicated Esophageal Candidiasis

(2015) J. Viljoen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Safety and Pharmacokinetics of Isavuconazole as Antifungal Prophylaxis in Acute Myeloid Leukemia Patients with Neutropenia: Results of a Phase 2, Dose Escalation Study

(2015) Oliver A. Cornely et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Multicenter Study of Isavuconazole MIC Distributions and Epidemiological Cutoff Values for the Cryptococcus neoformans-Cryptococcus gattii Species Complex Using the CLSI M27-A3 Broth Microdilution Method

(2014) A. Espinel-Ingroff et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VitroAntifungal Activity of Isavuconazole against 345 Mucorales Isolates Collected at Study Centers in Eight Countries

(2014) P.E. Verweij et al.   JOURNAL OF CHEMOTHERAPY

Isavuconazole Treatment of a Patient with Disseminated Mucormycosis

(2014) D. Peixoto et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Architecture of a single membrane spanning cytochrome P450 suggests constraints that orient the catalytic domain relative to a bilayer

(2014) B. C. Monk et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Determination of Isavuconazole Susceptibility of Aspergillus and Candida Species by the EUCAST Method

(2013) Susan J. Howard et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Isavuconazole Pharmacodynamic Target Determination for Candida Species in anIn VivoMurine Disseminated Candidiasis Model

(2013) Alexander J. Lepak et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Isavuconazole (BAL4815) Pharmacodynamic Target Determination in anIn VivoMurine Model of Invasive Pulmonary Aspergillosis against Wild-Type andcyp51Mutant Isolates of Aspergillus fumigatus

(2013) Alexander J. Lepak et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Multicenter Study of Isavuconazole MIC Distributions and Epidemiological Cutoff Values for Aspergillus spp. for the CLSI M38-A2 Broth Microdilution Method

(2013) A. Espinel-Ingroff et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Evaluation of intravenous voriconazole in patients with compromised renal function

(2013) Craig M Lilly et al.   BMC INFECTIOUS DISEASES

Successful isavuconazole salvage therapy in a patient with invasive mucormycosis

(2013) J. Ervens et al.   INFECTION

Isavuconazole Activity against Aspergillus lentulus, Neosartorya udagawae, and Cryptococcus gattii, Emerging Fungal Pathogens with Reduced Azole Susceptibility

(2013) K. Datta et al.   JOURNAL OF CLINICAL MICROBIOLOGY

In Vitro Activities of Isavuconazole and Comparator Antifungal Agents Tested against a Global Collection of Opportunistic Yeasts and Molds

(2013) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Risk factors for early mortality in haematological malignancy patients with pulmonary mucormycosis

(2013) Russell E. Lewis et al.   MYCOSES

Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study

(2013) Russell E. Lewis et al.   MYCOSES

Posaconazole Pharmacodynamic Target Determination against Wild-Type andCyp51Mutant Isolates of Aspergillus fumigatus in anIn VivoModel of Invasive Pulmonary Aspergillosis

(2012) Alexander J. Lepak et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Epidemiology and Clinical Manifestations of Mucormycosis

(2012) George Petrikkos et al.   CLINICAL INFECTIOUS DISEASES

Mucormycosis treated with posaconazole: review of 96 case reports

(2012) Joerg J. Vehreschild et al.   CRITICAL REVIEWS IN MICROBIOLOGY

Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3)

(2012) A. Skiada et al.   HAEMATOLOGICA

How I treat mucormycosis

(2011) D. P. Kontoyiannis et al.   BLOOD

Use of antifungal agents in pediatric and adult high-risk areas

(2011) E. Ramírez et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Three-dimensional models of 14α-sterol demethylase (Cyp51A) from Aspergillus lentulus and Aspergillus fumigatus: an insight into differences in voriconazole interaction

(2011) Laura Alcazar-Fuoli et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success

(2010) D P Kontoyiannis   BONE MARROW TRANSPLANTATION

Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant‐Associated Infection Surveillance Network (TRANSNET)

(2010) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Isavuconazole: A Comprehensive Review of Spectrum of Activity of a New Triazole

(2010) George R. Thompson et al.   MYCOPATHOLOGIA

In Vitro Activity of the New Azole Isavuconazole (BAL4815) Compared with Six Other Antifungal Agents against 162 Cryptococcus neoformans Isolates from Cuba

(2008) M.-T. Illnait-Zaragozi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Antifungal Activities of Isavuconazole (BAL4815), Voriconazole, and Fluconazole against 1,007 Isolates of Zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium Species

(2008) J. Guinea et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES

Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry

(2008) D. Neofytos et al.   CLINICAL INFECTIOUS DISEASES

Pediatric Antifungal Utilization

(2008) Priya A. Prasad et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL